Tequin - Gatifloxacin

Modified on 2010/08/04 09:26 by Chrissie Cole
In May 2006, government watchdog Public Citizen petitioned the U.S. Food and Drug Administration to ban Tequin due to reports of blood sugar problems that have been linked to 20 deaths and over 150 hospitalizations.

Tequin, also known as gatifloxacin, is an antibiotic used to treat adults with lung, sinus, or urinary tract infections and also to treat certain sexually transmitted diseases caused by germs called bacteria. Sometimes viruses, rather than bacteria, may infect the lungs and sinuses (for example, the common cold). Tequin, like all other antibiotics, does not kill viruses.

The sexually transmitted disease called gonorrhea is treated by Tequin. Other sexually transmitted diseases including syphilis and non-gonococcal diseases are not treated by Tequin.

Tequin, which belongs to the class of drugs known as fluoroquinolones, is manufactured by Bristol-Myers Squibb. The U.S. Food and Drug Administration approved Tequin in 1999.

Potential side effects of Tequin include, but may not be limited to, nausea, vomiting, stomach pain, diarrhea, dizziness and headache.

Fluoroquinolones such as Tequin have been linked to serious side effects. The medication should stop being used immediately if a patient experiences any of the following symptoms:
  • An allergic reaction (difficulty breathing; closing of the throat; swelling of the lips, tongue, or face; or hives)
  • Central nervous system (CNS) side effects including: seizures, dizziness, confusion, tremors, hallucinations, depression, or suicidal thoughts
  • Pain, inflammation, or rupture of a tendon
  • Hematologic and immunologic adverse reactions
  • Liver problems

In 2006, Bristol-Myers announced labeling changes for Tequin. The labeling changes, announced by the Tequin manufacturer in a letter to healthcare professionals, update the prescription information as a result of continued reports of serious cases of hypoglycemia (low blood sugar) and hyperglycemia (high blood sugar) in patients receiving Tequin. Since the approval of Tequin in 1999, there have been rare cases of life-threatening events reported globally in patients treated with the drug. Most of these events were reversible when properly managed, but a few had fatal outcomes.

If you have taken this drug, it may be advisable to seek both medical attention to protect your health and legal counseling to protect your rights. Please keep in mind that there may be time limits within which you must commence suit.

See Also

  1. Antibiotics
  2. Balance Problems: Overview
  3. Blood Disorders: Overview
  4. Diarrhea: Overview
  5. Head, Spinal Cord, Brain & Nerve Disorders: Overview
  6. Headaches
  7. Hypoglycemia
  8. Immune Disorders
  9. Liver Problems
  10. Nausea: Overview
  Name Size